共 7 条
[1]
Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK)[J] Christopher S Gray;Anthony J Hildreth;Peter A Sandercock;Janice E O'Connell;Donna E Johnston;Niall EF Cartlidge;John M Bamford;Oliver F James;K George MM Alberti Lancet Neurology 2007,
[2]
Imaging of the brain and cerebral vasculature in patients with suspected stroke: Advantages and disadvantages of CT and MRI[J] Chelsea S. Kidwell;Amie W. Hsia Current Neurology and Neuroscience Reports 2006,
[3]
Extending Reperfusion Therapy for Acute Ischemic Stroke: Emerging Pharmacological; Mechanical; and Imaging Strategies[J] Carlos A. Molina;Jeffrey L. Saver Stroke 2005,
[4]
The syndrome of irreversible acidosis after prolonged propofol infusion[J] Monisha A. Kumar;Victor C. Urrutia;Carole E. Thomas;Karine J. Abou-Khaled;Robert J. Schwartzman Neurocritical Care 2005,
[5]
Admission Fibrinolytic Profile Is Associated With Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Tissue Plasminogen Activator[J] Marc Ribo;Joan Montaner;Carlos A. Molina;Juan F. Arenillas;Esteban Santamarina;Manuel Quintana;José Alvarez-Sabín Stroke 2004,
[6]
Osmotic therapy[J] Michael N. Diringer;Allyson R. Zazulia Neurocritical Care 2004,
[7]
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial[J] Philip MW Bath;Ewa Lindenstrom;Gudrun Boysen;Peter De Deyn;Pal Friis;Didier Leys;Reijo Marttila;Jan-Edwin Olsson;Desmond O'Neill;Jean-Marc Orgogozo;Bernd Ringelstein;Jan-Jacob van der Sande;Alexander GG Turpie The Lancet 2001,